MENU
ATOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Atossa Therapeutics (ATOS) Earnings Date & Reports

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology... Show more

A.I. Advisor
published Earnings

ATOS is expected to report earnings to rise 20.00% to -5 cents per share on August 18

Atossa Therapeutics ATOS Stock Earnings Reports
Q2'25
Est.
$-0.06
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Est.
$-0.06
Q2'24
Beat
by $0.01
The last earnings report on May 13 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 573.41K shares outstanding, the current market capitalization sits at 121.69M.
View a ticker or compare two or three
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of products for breast cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
107 Spring Street
Phone
+1 206 588-0256
Employees
12
Web
https://www.atossatherapeutics.com